HealthUnlockedHealthUnlocked
AboutLog in

Experiences with

Acute respiratory distress syndrome (ARDS)

Acute respiratory distress syndrome (ARDS) is a life-threatening condition where the lungs cannot provide the body's vital organs with enough oxygen.

It's usually a complication of a serious existing health condition. This means most people are already in hospital by the time they develop ARDS.

Symptoms of ARDS

Symptoms of ARDS can include:

  • severe shortness of breath
  • rapid, shallow breathing
  • tiredness, drowsiness or confusion
  • feeling faint

When to get urgent medical help

Although most people get ARDS when they're already in hospital, this is not always the case. It can start quickly as a result of an infection, such as pneumonia, or if someone accidentally inhales their vomit.

Call 999 immediately to ask for an ambulance if a child or adult is having breathing problems.

What causes ARDS?

ARDS happens when the lungs become severely inflamed from an infection or injury. The inflammation causes fluid from nearby blood vessels to leak into the tiny air sacs in your lungs, making breathing increasingly difficult.

The lungs can become inflamed after:

  • pneumonia or severe flu
  • sepsis
  • a severe chest injury
  • accidentally inhaling vomit, smoke or toxic chemicals
  • near drowning
  • acute pancreatitis – a serious condition where the pancreas becomes inflamed over a short time
  • an adverse reaction to a blood transfusion

Diagnosing ARDS

There's no specific test to diagnose ARDS. A full assessment is needed to identify the underlying cause and rule out other conditions.

The assessment is likely to include:

  • a physical examination
  • blood tests to measure the amount of oxygen in the blood and check for an infection
  • a pulse oximetry test, where a sensor attached to your fingertip, ear or toe is used to measure how much oxygen your blood is absorbing
  • a chest X-ray and a CT scan to look for evidence of ARDS
  • an echocardiogram – a type of ultrasound scan that's used to look at your heart and nearby blood vessels

Treating ARDS

If you develop ARDS, you'll probably be admitted to an intensive care unit (ICU) and use a breathing machine (ventilator) to help your breathing.

You breathe through a mask attached to the machine. If your breathing is severely affected, a breathing tube may be inserted down your throat and into your lungs.

Fluids and nutrients will be supplied through a feeding tube (nasogastric tube) that's passed through your nose and into your stomach.

The underlying cause of ARDS should also be treated. For example, if it's caused by a bacterial infection, you may need antibiotics.

How long you'll need to stay in hospital depends on your individual circumstances and the cause of ARDS. Most people respond well to treatment, but it may be several weeks or months before you're well enough to leave hospital.

Complications of ARDS

Because ARDS is often caused by a serious health condition, about 1 in 3 people who get it will die. But most deaths are the result of the underlying illness, rather than ARDS itself.

For those who survive, the main complications are linked with nerve and muscle damage, which causes pain and weakness.

Some people also develop psychological problems, such as post-traumatic stress disorder (PTSD) and depression.

The lungs usually recover and long-term lung failure after ARDS is rare.

HealthUnlocked contains information from NHS Digital, licensed under the current version of the Open Government Licence

  • Posts

  • Communities

9,466 public posts

Fewer fungi types in lungs linked to worse disease in acute respiratory distress syndrome.

Many COVID-19 patients develop acute respiratory distress syndrome (ARDS), a life-threatening condition where the lungs cannot provide the body's vital organs with enough oxygen. Patients with ARDS are usually placed on ventilators to help get enough oxygen into their bodies.
Many COVID-19 patients develop acute respiratory distress syndrome (ARDS), a life-threatening condition where the lungs cannot provide the body's vital organs with enough oxygen. Patients with ARDS are usually placed on ventilators to help get enough oxygen into their bodies.
2greys
in British Lung Foundation

Possible treatment for Acute respiratory distress syndrome in Covid-19

Acute respiratory distress syndrome (ARDS) is a complication that can be fatal in Covid-19. The doctors received approval to test their ARDS therapy late last year and have tested T3 on two patients who survived Covid-19 after the therapy.
Acute respiratory distress syndrome (ARDS) is a complication that can be fatal in Covid-19. The doctors received approval to test their ARDS therapy late last year and have tested T3 on two patients who survived Covid-19 after the therapy.
lynmynottAdministrator
in Thyroid UK

Will COVID-19 Survivors Require a Lung Transplant in the Future?

Although doctors are currently uncertain about the long-term effects of COVID-19 on the lungs of those who get the disease, they do know that patients who recover from an episode of severe acute respiratory distress syndrome (ARDS), a secondary condition that can be caused by infections like COVID-19
Although doctors are currently uncertain about the long-term effects of COVID-19 on the lungs of those who get the disease, they do know that patients who recover from an episode of severe acute respiratory distress syndrome (ARDS), a secondary condition that can be caused by infections like COVID-19
2greys
in British Lung Foundation
Want to take advantage of all our features? Just log in!
or

Study Shows Endothelial Cell Targeting Could Help Fight Covid-19 Symptoms.

Yet how SARS2 dysregulates vascular functions causing an acute respiratory distress syndrome (ARDS) in Covid-19 patients remains an enigma. https://news.stonybrook.edu/newsroom/press-release/medical/study-shows-endothelial-cell-targeting-could-help-fight-covid-19-symptoms/ mBio.
Yet how SARS2 dysregulates vascular functions causing an acute respiratory distress syndrome (ARDS) in Covid-19 patients remains an enigma. https://news.stonybrook.edu/newsroom/press-release/medical/study-shows-endothelial-cell-targeting-could-help-fight-covid-19-symptoms/ mBio.
2greys
in British Lung Foundation

Almost a third of young adults with asthma are ignoring COVID-19 guidelines, says survey.

During the first, the clinical picture is characterized by dry cough, dyspnea, diarrhea, general malaise, and fever, which can progress to pneumonia (stage 2) and then acute respiratory distress syndrome (stage 3).
During the first, the clinical picture is characterized by dry cough, dyspnea, diarrhea, general malaise, and fever, which can progress to pneumonia (stage 2) and then acute respiratory distress syndrome (stage 3).
2greys
in British Lung Foundation

University of Miami leads groundbreaking trial for COVID-19 treatment.

Results: treatment group vs. control group The paper describes findings from 24 patients hospitalized at University of Miami Tower or Jackson Memorial Hospital with COVID-19 who developed severe acute respiratory distress syndrome.
Results: treatment group vs. control group The paper describes findings from 24 patients hospitalized at University of Miami Tower or Jackson Memorial Hospital with COVID-19 who developed severe acute respiratory distress syndrome.
2greys
in British Lung Foundation

Two Clinical Trials Use Low-DoseRadiation to Treat COVID-19 Infections.

Two clinical trials are applying a modern version of this concept to test patients who have acute respiratory distress syndrome (ARDS) as a result of COVID-19 infection.
Two clinical trials are applying a modern version of this concept to test patients who have acute respiratory distress syndrome (ARDS) as a result of COVID-19 infection.
2greys
in British Lung Foundation

Drug trial that could improve respiratory recovery from COVID-19 now underway.

Almitrine bismesylate, a drug first developed in France, has been successful in treating acute respiratory distress syndrome by constricting the blood vessels in regions of the lung where the oxygen is low.
Almitrine bismesylate, a drug first developed in France, has been successful in treating acute respiratory distress syndrome by constricting the blood vessels in regions of the lung where the oxygen is low.
2greys
in British Lung Foundation

Lungs of deceased COVID-19 patients show distinctive features.

They compared this group to seven autopsied lungs obtained from patients who died of acute respiratory distress syndrome secondary to influenza A (H1N1) infection as well as to 10 age-matched uninfected control lungs. https://www.nejm.org/doi/10.1056/NEJMoa2015432
They compared this group to seven autopsied lungs obtained from patients who died of acute respiratory distress syndrome secondary to influenza A (H1N1) infection as well as to 10 age-matched uninfected control lungs. https://www.nejm.org/doi/10.1056/NEJMoa2015432
2greys
in British Lung Foundation

Researchers identify 'druggable' signaling pathway that stimulates lung tissue repair.

The findings, which were published today in Nature Cell Biology, could lead to better therapies for patients with lung disease, including acute respiratory distress syndrome (ARDS) due to COVID-19. G. Scott Worthen, MD G.
The findings, which were published today in Nature Cell Biology, could lead to better therapies for patients with lung disease, including acute respiratory distress syndrome (ARDS) due to COVID-19. G. Scott Worthen, MD G.
2greys
in British Lung Foundation

Air Hunger and Psychological Trauma in Ventilated COVID-19 Patients: An Urgent Problem.

A key therapeutic strategy will be lung protective ventilation, an approach that entails low tidal volumes and permissive hypercapnia, for treatment of acute respiratory distress syndrome (ARDS) caused by the virus.
A key therapeutic strategy will be lung protective ventilation, an approach that entails low tidal volumes and permissive hypercapnia, for treatment of acute respiratory distress syndrome (ARDS) caused by the virus.
2greys
in British Lung Foundation

How rod-shaped particles might distract an out-of-control COVID immune response.

This is called acute respiratory distress syndrome. But a new way of drawing immune cells out of the lungs might be able to prevent this outcome.
This is called acute respiratory distress syndrome. But a new way of drawing immune cells out of the lungs might be able to prevent this outcome.
2greys
in British Lung Foundation

Dilated blood vessels in the lung may explain low oxygen levels in severe cases of COVID-19.

This vasodilation is contributing to the very low oxygen levels seen in COVID-19 respiratory failure and also helps explain why the disease behaves differently than classic acute respiratory distress syndrome (ARDS).
This vasodilation is contributing to the very low oxygen levels seen in COVID-19 respiratory failure and also helps explain why the disease behaves differently than classic acute respiratory distress syndrome (ARDS).
2greys
in British Lung Foundation

WATCH: Israeli Drug Could Treat Condition That Kills 50% of Corona Patients

An Israeli company called Neurorx‏ is currently testing a drug called Aviptadil, which could treat acute respiratory distress syndrome (ARDS), the condition responsible for around 50% of all coronavirus fatalities. On Sunday, the U.S.
An Israeli company called Neurorx‏ is currently testing a drug called Aviptadil, which could treat acute respiratory distress syndrome (ARDS), the condition responsible for around 50% of all coronavirus fatalities. On Sunday, the U.S.
lupus-support1Administrator
in LUpus Patients Understanding and Support

Oxytocin’s anti-inflammatory and proimmune functions in COVID-19.

Cytokine storms are characterized by a severe inflammatory response triggering a series of immune responses that causes changes in lymphocytes, which can rapidly progress into acute respiratory distress syndrome (ARDS), damage to the alveolar lumen, often followed by multiorgan failure.
Cytokine storms are characterized by a severe inflammatory response triggering a series of immune responses that causes changes in lymphocytes, which can rapidly progress into acute respiratory distress syndrome (ARDS), damage to the alveolar lumen, often followed by multiorgan failure.
2greys
in British Lung Foundation

Melatonin as potential Covid-19 adjuvant treatment

This leads to a cytokine storm and subsequent progression to acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and often death. Melatonin, a well-known anti-inflammatory and anti-oxidative molecule, is protective against ALI/ARDS caused by viral and other pathogens.
This leads to a cytokine storm and subsequent progression to acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and often death. Melatonin, a well-known anti-inflammatory and anti-oxidative molecule, is protective against ALI/ARDS caused by viral and other pathogens.
Graham49
in Advanced Prostate Cancer

Survival of Hospitalized Patients With Concurrent COVID-19 and Hematological Malignancies

The development of acute respiratory distress syndrome, an ECOG performance status ≥2, and qSOFA score ≥2 were associated with shorter survival.
The development of acute respiratory distress syndrome, an ECOG performance status ≥2, and qSOFA score ≥2 were associated with shorter survival.
JT_Marlin
in MPN Voice

Can this Israeli corovavirus drug 'completely prevent' lung damage?

Israel’s Pluristem Therapeutics’ PLX cells therapy, which is also based on MSCs, has already been cleared by the US Food and Drug Administration for a Phase II study for the treatment of severe COVID-19 cases complicated by Acute Respiratory Distress Syndrome.
Israel’s Pluristem Therapeutics’ PLX cells therapy, which is also based on MSCs, has already been cleared by the US Food and Drug Administration for a Phase II study for the treatment of severe COVID-19 cases complicated by Acute Respiratory Distress Syndrome.
lupus-support1Administrator
in LUpus Patients Understanding and Support

Masking while exposed to COVID infection, can be protective through "variolation"

[/i] [i]"SARS-CoV-2 has the protean ability to cause myriad clinical manifestations, ranging from a complete lack of symptoms to pneumonia, acute respiratory distress syndrome, and death.
[/i] [i]"SARS-CoV-2 has the protean ability to cause myriad clinical manifestations, ranging from a complete lack of symptoms to pneumonia, acute respiratory distress syndrome, and death.
MateoBeach
in Advanced Prostate Cancer

Novel Israeli Therapy Takes Aim at Coronavirus

“The primary target is to prevent the deterioration of patients towards Acute Respiratory Distress Syndrome (ARDS) and sepsis. We intend to start the joint collaboration immediately, with an aim to bringing much needed treatment to a rapidly expanding global health threat.”
“The primary target is to prevent the deterioration of patients towards Acute Respiratory Distress Syndrome (ARDS) and sepsis. We intend to start the joint collaboration immediately, with an aim to bringing much needed treatment to a rapidly expanding global health threat.”
lupus-support1Administrator
in LUpus Patients Understanding and Support
  • 1
  • 2
  • ...
  • 100
  • Next page
  • 10
  • 20
  • 30
  • 40
  • 50
  • 60
  • 70
  • 80
  • 90
  • 100
Filter results
Posted in
Sort by
HealthUnlocked
© 2021 All rights reserved.
App store
★ ★ ★ ★ ★ Average rating: 4.8

Company

About Us

Our Team

Partner with us

Careers

Blog

Product

Health terms A to Z

Communities A to Z

iPhone app

Start a Community

Support

Help Centre

Community Guidelines

Contact us

Cookies settings

App store
★ ★ ★ ★ ★ Average rating: 4.8
TermsPrivacySecurityCookies